Prevalence of Use of Herbal Medicines for the Treatment of Sickle Cell Disease in Africa: a Systematic Review and Meta-analysis

Adejumo, 2012, Moringa oleifera Lam. (Moringaceae) grown in Nigeria: in vitro antisickling activity on deoxygenated erythrocyte cells, J. Pharm. Bioallied Sci., 4, 118, 10.4103/0975-7406.94812 Adejumo, 2010, In vitro antisickling activities and phytochemical evaluation of Plumbago zeylanica and Uvaria chamae, Afr. J. Biotechnol., 9, 9032 Adejumo, 2011, Phytochemical and antisickling activities of Entandrophragma utile Chenopodium ambrosioides Petiveria alliacea, J. Med. Plant Res., 5, 1531 Akinsulie, 2005, Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia, J. Trop. Pedia., 51, 200, 10.1093/tropej/fmh097 Ameh, 2012, Traditional herbal management of sickle cell anemia: lessons from Nigeria, Anemia, 2012, 10.1155/2012/607436 Amone, C.2014. We are strong because of our millet bread: staple foods and the growth of ethnic identities in Uganda. Gulu University-Northern Uganda and Millersville University of Pennsylvania. Retrieved February from 〈https://www.thefreelibrary.com/We+are+strong+because+of+our+millet+bread%3A+staple+foods+and+the.-a0372251488〉, 〈https://www.researchgate.net/profile/Charles-Amone〉. Amoran, 2017, Prevention practices influencing frequency of occurrence of vaso-occlusive crisis among sickle cell patients in Abeokuta South Local Government Area of Ogun State, Nigeria, BMC Hematol., 17, 6, 10.1186/s12878-017-0077-9 Anyanwu, 2016, Novel use of hydroxyurea in an African region with malaria: protocol for a randomized controlled clinical trial, JMIR Res Protoc., 5, 10.2196/resprot.5599 Bianchi, 2009, Fetal hemoglobin inducers from the natural world: a novel approach for identification of drugs for the treatment of β-thalassemia and sickle-cell anemia, Evid. Based Complement. Altern. Med., 6, 141, 10.1093/ecam/nem139 Booth, 2022, Treatment decision-making in sickle cell disease patients, J. Community Genet., 13, 143, 10.1007/s12687-021-00562-z Brooke, 2021, MOOSE reporting guidelines for meta-analyses of observational studies, JAMA Surg., 156, 787, 10.1001/jamasurg.2021.0522 Busari, 2017, High prevalence of complementary and alternative medicine use among patients with sickle cell disease in a tertiary hospital in Lagos, South West, Nigeria, BMC Complement. Altern. Med., 17, 299, 10.1186/s12906-017-1812-2 Chen, 2018, The characteristics and prescription patterns of Chinese herbal medicine in clinical practice for the treatment of anemia, Taiwan. J. Obstet. Gynecol., 57, 570, 10.1016/j.tjog.2018.06.030 Cordeiro, 2004, Phytomedicines (medicines derived from plants) for sickle cell disease, Cochrane Database Syst. Rev., 3, Cd004448 DailyTrust_reporter, 2022. How NIPRISAN is improving access to sickle cell treatment in Nigeria. Daily Trust. https://dailytrust.com/how-niprisan-is-improving-access-to-sickle-cell-treatment-in-nigeria/ (Accessed March 8, 2022). DeBaun Michael, Matthew Heeney, Terry Jackson, Dan Longo, Melesa Love, Trinity Love, Phillip Okwo, Alexis Thompson, Cassandra Trimnell, Teonna Woolford, 2022. Sickle cell disease in sub-Saharan Africa. UpToDate, 2022 (August 2022). 〈https://www.uptodate.com/contents/sickle-cell-disease-in-sub-saharan-africa#H243231〉. Egunyomi, 2009, Antisickling activities of two ethnomedicinal plant recipes used for the management of sickle cell anaemia in Ibadan, Nigeria, Afr. J. Biotechnol., 8, 20 Ekeke, 1985, The reversion of sickled cells by Cajanus cajan, Planta Med., 51, 504, 10.1055/s-2007-969576 Gour, 2022, Investigating the potential use of andrographolide as a coadjuvant in sickle cell anemia therapy, ACS Omega, 7, 12765, 10.1021/acsomega.1c07339 Ibrahim, 2007, Phytochemical and antisickling studies of the leaves of Hymenocardia acida tul (Euphorbiaceae), Pak. J. Biol. Sci., 10, 788, 10.3923/pjbs.2007.788.791 Imaga, 2013, Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia, ScientificWorldJournal, 2013, 10.1155/2013/269659 Imaga, 2010, The use of phytomedicines as effective therapeutic agents in sickle cell anemia, Sci. Res. ESSAYS, 5, 3803 Independent_Reporter, 2021. Caretakers of sicklers decry high price of hydroxyurea. The Independent. https://www.independent.co.ug/caretakers-of-sicklers-decry-high-price-of-hydroxyurea/. Kitadi, 2020, Ethnopharmacological survey and antisickling activity of plants used in the management of sickle cell disease in Kikwit City, DR Congo, Evid. Based Complement Altern. Med, 2020, 1346493, 10.1155/2020/1346493 Lubega, 2021, Use of herbal medicine by caregivers in the management of children with sickle cell disease in Mulago National Referral Hospital-Uganda, PAN Afr. Med. J., 39, 163 Misra, 2013, Traditional and indigenous system of medicine in Nigeria, Planta Med., 79, 10.1055/s-0033-1352036 Moody, 2003, Anti-sickling potential of a Nigerian herbal formula (Ajawaron HF) and the major plant component (Cissus populnea L. CPK), Phytother. Res., 17, 1173, 10.1002/ptr.1323 Moore, 2000, Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, Am. J. Hematol., 64, 26, 10.1002/(SICI)1096-8652(200005)64:1<26::AID-AJH5>3.0.CO;2-F Mpianaa, 2008, Antisickling activity of anthocyanins from Bombax pentadrum, Ficus capensis and Ziziphus mucronata: photodegradation effect, J. Ethnopharmacol., 120, 413, 10.1016/j.jep.2008.09.012 Munn, 2015, Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data, Int. J. Evid. Based Health, 13, 147, 10.1097/XEB.0000000000000054 Mvundura, 2019, Cost for sickle cell disease screening using isoelectric focusing with dried blood spot samples and estimation of price thresholds for a point-of-care test in Uganda, J. Blood Med., 10, 59, 10.2147/JBM.S186528 Nanfack Pauline, 2013, The in vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitzii on sickle cell disorder, BMC Complement Alter. Med, 13, 162, 10.1186/1472-6882-13-162 NHS, 2022. Herbal medicine. National Health Service, UK. https://www.nhs.uk/conditions/herbal-medicines/ (Accessed April 25, 2023). Nsimba, 2013, Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture, J. Ethnopharmacol., 146, 594, 10.1016/j.jep.2013.01.031 Nsimba, 2013, Decreased thrombin activity by a Congolese herbal medicine used in sickle cell anemia, J. Ethnopharmacol., 148, 895, 10.1016/j.jep.2013.05.038 Obodozie, 2010, A normative study of the components of niprisan--an herbal medicine for sickle cell anemia, J. Diet. Suppl., 7, 21, 10.3109/19390210903534988 Odame, 2022, Sickle cell disease in children: an update of the evidence for WHO guideline development, Arch. Dis. Child. Ofakunrin, 2021, Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria, Afr. Health Sci., 21, 765, 10.4314/ahs.v21i2.36 Ofakunrin, 2020, Effectiveness and safety of hydroxyurea in the treatment of sickle cell anaemia children in Jos, North Central Nigeria, J. Trop. Pediatr., 66, 290, 10.1093/tropej/fmz070 Ogwang, 2008, Repeat-dose effects of Zanthoxylum chalybeum root bark extract: a traditional medicinal plant used for various diseases in Uganda, Afr. J. Pharm. Pharmacol., 2, 101 Okagu, 2021, Zanthoxylum species: a comprehensive review of traditional uses, phytochemistry, pharmacological and nutraceutical applications, Molecules, 26, 4023, 10.3390/molecules26134023 Okoh, 2019, Herbal drug use in sickle cell disease management; trends and perspectives in sub-Saharan Africa - a systematic review, Curr. Drug Discov. Technol., 16, 372, 10.2174/1570163815666181002101611 Onen, 2017, Ethno-botanical uses of Ugandan edible wild fruit species, Environ. Earth Ecol., 1, 62, 10.24051/eee/80760 Opoka, 2017, Novel use of Hydroxyurea in an African region with Malaria (NOHARM): a trial for children with sickle cell anemia, Blood, 130, 2585, 10.1182/blood-2017-06-788935 Opoka, 2020, Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort, Haematologica, 105, e272, 10.3324/haematol.2019.231407 Oshikoya, 2008, Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria, BMC Complement. Altern. Med., 8, 66, 10.1186/1472-6882-8-66 Ouattara, 2009, Antisickling properties of divanilloylquinic acids isolated from Fagara zanthoxyloides Lam. (Rutaceae), Phytomedicine, 16, 125, 10.1016/j.phymed.2008.10.013 Ouédraogo, 2019, Morphological and molecular characterization of Zanthoxylum zanthoxyloides (Rutaceae) from Burkina Faso, Plants, 8, 353, 10.3390/plants8090353 Pace, 2006, Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction, Dev. Dyn., 235, 1727, 10.1002/dvdy.20802 Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372, n71, 10.1136/bmj.n71 Park, 2019, Acute hydroxyurea treatment reduces tubular damage following bilateral ischemia-reperfusion injury in a mouse model of sickle cell disease, Biochem. Biophys. Res Commun., 515, 72, 10.1016/j.bbrc.2019.05.116 Ramde-Tiendrebeogo, 2014, Study of antisickling and vasorelaxant activities and acute toxicity assessment of crude extracts of leaves of Ficus sycomorus L. (Moraceae), Pak. J. Biol. Sci.: PJBS, 17, 829, 10.3923/pjbs.2014.829.835 Rees, 2010, Sickle-cell disease, Lancet, 376, 2018, 10.1016/S0140-6736(10)61029-X Tchacondo, 2012, Medicinal plants use in central Togo (Africa) with an emphasis on the timing, Pharmacogn. Res., 4, 92, 10.4103/0974-8490.94724 Towns, 2014, Traditional medicine and childcare in Western Africa: Mothers’ knowledge, folk illnesses, and patterns of healthcare-seeking behavior, PLoS One, 9, 10.1371/journal.pone.0105972 URN, 2020. Ministry of Health launches sickle cell treatment guidelines. The independent. Available at: 〈https://www.independent.co.ug/ministry-of-health-launches-sickle-cell-treatment-guidelines/〉. Wambebe, 2001, Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN (R) in patients with Sickle Cell Disorder, Phytomedicine, 8, 252, 10.1078/0944-7113-00040 Wambebe, 2001, Efficacy of niprisan in the prophylactic management of patients with sickle cell disease, Curr. Ther. Res. - Clin. Exp., 62, 26, 10.1016/S0011-393X(01)80039-4 Wastnedge, 2018, The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis, J. Glob. Health, 8, 10.7189/jogh.08.021103 World_Health_Organization, 2013. WHO traditional medicine strategy 2014–2023. World health organization. 〈https://apps.who.int/iris/bitstream/handle/10665/92455/9789241506090_eng.pdf;jsessionid=B9166787DDB6CF0BF153CFF7D3274671?sequence=1〉. World_Health_Organization, 2022. Sickle cell disease. World Health Organization Africa. Retrieved February from 〈https://www.afro.who.int/health-topics/sickle-cell-disease〉, 〈https://www.afro.who.int/news/african-health-ministers-launch-drive-curb-sickle-cell-disease-toll〉. Yembeau, 2022, Ethnopharmacological study of the medicinal plants used in the treatment of sickle cell anemia in the West region of Cameroon, Evid. Based Complement Altern. Med, 2022, 5098428, 10.1155/2022/5098428